Literature DB >> 10716624

Fibroblast growth factor-2.

M Okada-Ban1, J P Thiery, J Jouanneau.   

Abstract

Fibroblast growth factor-2 (FGF-2) is a heparin-binding growth factor which occurs in several isoforms resulting from alternative initiations of translation: an 18 kD cytoplasmic isoform and four larger molecular weight nuclear isoforms (22, 22.5, 24 and 34 kD). FGF-2 has pleiotropic roles in many cell types and tissues; it is a motogenic, angiogenic and survival factor which is involved in cell migration, cell differentiation and in a variety of developmental processes. Although devoid of signal peptide, it could be secreted. It acts mainly through a paracrine/autocrine mechanism involving high affinity transmembrane receptors and heparan sulfate proteoglycan low affinity receptors, but also through still unknown intracrine process(es) on intracellular targets. FGF-2 has many biological functions which are probably isoform-specific. Nevertheless, FGF-2 is not essential for embryonic development as knock-out mice for the growth factor are viable and fertile although they exhibit abnormalities in neuronal differentiation. Use of FGF-2 as therapeutic agent for the treatment of ischemic cardiovascular disease is promising and clinical trials are in progress.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10716624     DOI: 10.1016/s1357-2725(99)00133-8

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  52 in total

1.  FGF-2 controls the differentiation of resident cardiac precursors into functional cardiomyocytes.

Authors:  Nathalie Rosenblatt-Velin; Mario G Lepore; Cristina Cartoni; Friedrich Beermann; Thierry Pedrazzini
Journal:  J Clin Invest       Date:  2005-06-09       Impact factor: 14.808

2.  Absorbable collagen sponge combined with recombinant human basic fibroblast growth factor promotes nerve regeneration in rat sciatic nerve.

Authors:  Cheng-Can Yao; Ping Yao; Hao Wu; Zhen-Gang Zha
Journal:  J Mater Sci Mater Med       Date:  2007-06-07       Impact factor: 3.896

Review 3.  Fibrogenesis and fibrosis in inflammatory bowel diseases: Good and bad side of same coin?

Authors:  Mariabeatrice Principi; Floriana Giorgio; Giuseppe Losurdo; Viviana Neve; Antonella Contaldo; Alfredo Di Leo; Enzo Ierardi
Journal:  World J Gastrointest Pathophysiol       Date:  2013-11-15

4.  A vaccine targeting basic fibroblast growth factor elicits a protective immune response against murine melanoma.

Authors:  Xiaoping Zhang; Neng-Lian Li; Chao Guo; Ying-Dong Li; Lu-Lu Luo; Yong-Qi Liu; Yun-Yan Duan; Zhen-Dong Li; Xiao-Rong Xie; Hai-Xia Song; Li-Ping Yang; Fang-Yu An
Journal:  Cancer Biol Ther       Date:  2018-03-06       Impact factor: 4.742

5.  [Effect of basic fibroblast growth factor antibody combined with irinotecan on proliferation and apoptosis of small cell lung cancer H223 cells in vitro].

Authors:  Xiang-Hui Liao; Meng Xu; Jun-Jian Xiang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-11-20

6.  (125)I-labeled anti-bFGF monoclonal antibody inhibits growth of hepatocellular carcinoma.

Authors:  Peng-Hui Hu; Lan-Hong Pan; Patrick Ting-Yat Wong; Wen-Hui Chen; Yan-Qing Yang; Hong Wang; Jun-Jian Xiang; Meng Xu
Journal:  World J Gastroenterol       Date:  2016-06-07       Impact factor: 5.742

Review 7.  Nuclear Fibroblast Growth Factor Receptor Signaling in Skeletal Development and Disease.

Authors:  Creighton T Tuzon; Diana Rigueur; Amy E Merrill
Journal:  Curr Osteoporos Rep       Date:  2019-06       Impact factor: 5.096

8.  PDGF, bFGF and IGF-I stimulate the proliferation of intervertebral disc cells in vitro via the activation of the ERK and Akt signaling pathways.

Authors:  Harris Pratsinis; Dimitris Kletsas
Journal:  Eur Spine J       Date:  2007-09-01       Impact factor: 3.134

9.  Ablation of low-molecular-weight FGF2 isoform accelerates murine osteoarthritis while loss of high-molecular-weight FGF2 isoforms offers protection.

Authors:  Patience M Burt; Liping Xiao; Thomas Doetschman; Marja M Hurley
Journal:  J Cell Physiol       Date:  2018-08-25       Impact factor: 6.384

10.  Characterization of human skin-derived mesenchymal stem cell proliferation rate in different growth conditions.

Authors:  Una Riekstina; Ruta Muceniece; Inese Cakstina; Indrikis Muiznieks; Janis Ancans
Journal:  Cytotechnology       Date:  2009-02-14       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.